[{"Assets_0_Q2_USD":239521000.0,"CommonStockSharesOutstanding_0_Q2_shares":630672578.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-70371000.0,"NetIncomeLoss_1_Q2_USD":-41087000.0,"NetIncomeLoss_2_Q2_USD":-68499000.0,"Ticker":"ADAP","CIK":"1621227","name":"ADAPTIMMUNE THERAPEUTICS PLC","OfficialName":"Adaptimmune Therapeutics plc American Depositary Shares","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"301181409.0","Country":"United Kingdom","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20190801"}]